FDA Approved: NAYZILAM — Supplemental Application (UCB, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Nayzilam (midazolam) from UCB, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Seizures

Drugs mentioned

• NAYZILAM (midazolam)

Snippet

SUPPL AP for NAYZILAM (MIDAZOLAM)